Featured Innovation Theater
UCB Program: Expert Perspectives on a New Treatment
Exhibit Hall, Innovation Theater A
Developed and offered by UCB (Non-CME)
Loading view.
Lightning Talk
NeuroImmune Modulation for Rheumatoid Arthritis
Exhibit Hall, Booth #3257
Developed and offered by SetPoint Medical (Non-CME)
Innovation Theater
Exploring the Clinical Profile of SAPHNELO® (anifrolumab-fnia): An Expert Review of the TULIP Pivotal Trials and 4-Year Long-Term Extension Study
Exhibit Hall, Innovation Theater B
Developed and offered by AstraZeneca (Non-CME)
Lightning Talk
The Importance of Preventing Kidney Flares in Lupus Nephritis
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
Lightning Talk
Reframing Lupus Nephritis Management
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
Lightning Talk
A Collaborative Approach to Clinical Practice Guidelines for Sjögren’s Disease
Exhibit Hall, Booth #3257
Developed and offered by Sjögren’s Foundation (Non-CME)
Lightning Talk
Sometimes the Culprit is Right in Front of You: Hypophosphatasia
Exhibit Hall, Booth #3257
Developed and offered by Alexion (Non-CME)
Lightning Talk
Moving Real World Research FORWARD
Exhibit Hall, Booth #3257
Developed and offered by National Databank for Rheumatic Diseases (Non-CME)
Lightning Talk
Mystery Diagnosis: Recognizing X-linked Hypophosphatemia (XLH)
Exhibit Hall, Booth #3257
Developed and offered by Kyowa Kirin (Non-CME)
Lightning Talk
Mystery Diagnosis: Recognizing XLH (Continued)
Exhibit Hall, Booth #3257
Developed and offered by Kyowa Kirin (Non-CME)
Lightning Talk
Q&A/Continue the Conversation
Exhibit Hall, Booth #3257
(Non-CME)
Featured Innovation Theater
Understanding Early Advanced Therapy Use in Lupus: A Treatment Evolution
Exhibit Hall, Innovation Theater A
Developed and offered by GSK (Non-CME)
Upcoming Featured Industry Events
Popular Articles
-
Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease
-
ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists
-
FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases
-
Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice
-
Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology